<?xml version='1.0' encoding='utf-8'?>
<document id="20831618"><sentence text="Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis."><entity charOffset="78-89" id="DDI-PubMed.20831618.s1.e0" text="clopidogrel" /></sentence><sentence text="To investigate whether proton pump inhibitors (PPIs) negatively affect clinical outcome in patients treated with clopidogrel"><entity charOffset="113-124" id="DDI-PubMed.20831618.s2.e0" text="clopidogrel" /></sentence><sentence text=" Systematic review and meta-analysis" /><sentence text=" Outcomes evaluated were combined major adverse cardiac events (MACE), myocardial infarction (MI), stent thrombosis, death and gastrointestinal bleeding" /><sentence text=" Studies included were randomized trials or post-hoc analyzes of randomized trials and observational studies reporting adjusted effect estimates" /><sentence text=" Twenty five studies met the selection criteria and included 159 138 patients" /><sentence text=" Administration of PPIs together with clopidogrel corresponded to a 29% increased risk of combined major cardiovascular events [risk ratio (RR) = 1"><entity charOffset="38-49" id="DDI-PubMed.20831618.s7.e0" text="clopidogrel" /></sentence><sentence text="29, 95% confidence intervals (CI) = 1" /><sentence text="15-1" /><sentence text="45] and a 31% increased risk of MI (RR = 1" /><sentence text="31, 95%CI = 1" /><sentence text="12-1" /><sentence text="53)" /><sentence text=" In contrast, PPI use did not negatively influence the mortality (RR = 1" /><sentence text="04, 95%CI = 0" /><sentence text="93-1" /><sentence text="16), whereas the risk of developing a gastrointestinal bleed under PPI treatment decreased by 50% (RR = 0" /><sentence text="50, 95% CI = 0" /><sentence text="37-0" /><sentence text="69)" /><sentence text=" The presence of significant heterogeneity might indicate that the evidence is biased, confounded or inconsistent" /><sentence text=" The sensitivity analysis, however, yielded that the direction of the effect remained unchanged irrespective of the publication type, study quality, study size or risk of developing an event" /><sentence text=" Two studies indicate that PPIs have a negative effect irrespective of clopidogrel exposure"><entity charOffset="71-82" id="DDI-PubMed.20831618.s23.e0" text="clopidogrel" /></sentence><sentence text=" In conclusion, concomitant PPI use might be associated with an increased risk of cardiovascular events but does not influence the risk of death" /><sentence text=" Prospective randomized trials are required to investigate whether a cause-and-effect relationship truly exists and to explore whether different PPIs worsen clinical outcome in clopidogrel treated patients as the PPI-clopidogrel drug-drug interaction does not seem to be a class effect"><entity charOffset="177-188" id="DDI-PubMed.20831618.s25.e0" text="clopidogrel" /></sentence><sentence text="" /></document>